Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Vivani Medical Inc VANI

Healthcare Medical Devices
Vivani Medical, Inc. is a preclinical-stage biopharmaceutical company. The Company develops miniaturized and subdermal implants utilizing its NanoPortal technology to enable the delivery of a range of medicines to treat chronic diseases. It is engaged in the development of the Company’s lead programs NPM-115 and NPM-119, is a GLP-1 implant candidates for the treatment of chronic weight... see more

Recent & Breaking News (NDAQ:VANI)

Researchers Present Latest Positive Results of Second Sight's Orion Visual Cortical Prosthesis Feasibility Study

Business Wire June 25, 2019

Second Sight to Present at 20th Annual B. Riley FBR Investor Conference

Business Wire May 16, 2019

Second Sight Reports First Quarter 2019 Financial Results

Business Wire May 15, 2019

Second Sight to Accelerate Development of Orion® Visual Cortical Prosthesis System

Business Wire May 15, 2019

Second Sight to Discuss First Quarter 2019 Financial Results on May 15, 2019 Conference Call

Business Wire May 8, 2019

Second Sight Medical Products, Inc. Presents Positive Interim Results at the Fifth Annual BRAIN Initiative® Investigators Meeting

Business Wire April 11, 2019

56 Stocks Moving In Thursday's Mid-Day Session

Benzinga.com  March 14, 2019

Second Sight Reports Fourth Quarter and Full Year 2018 Financial Results

Business Wire March 13, 2019

Second Sight to Discuss Fourth Quarter and Year-End 2018 Financial Results on March 13, 2019 Conference Call

Business Wire March 6, 2019

Second Sight Medical Products, Inc. Announces Completion of Rights Offering

Business Wire February 21, 2019

Recent Analysis Shows Abercrombie & Fitch, DaVita, W.W. Grainger, Ingredion, FirstEnergy, and Second Sight Medical Products Market Influences — Renewed Outlook, Key Drivers of Growth

GlobeNewswire January 22, 2019

Second Sight Medical Products, Inc. Announces $40 Million Rights Offering of Units and Two Year Extension of Warrants (EYESW) Expiration Date

GlobeNewswire January 7, 2019

Second Sight Reports Fourth Quarter 2018 Business Update

GlobeNewswire January 7, 2019

Second Sight to Present at Digital Medicine and Medtech Showcase 2019

GlobeNewswire December 20, 2018

Second Sight Completes $3 million Private Placement of Common Stock with Gregg Williams, Chairman of the Board of Directors

GlobeNewswire December 14, 2018

The Daily Biotech Pulse: Axovant In-Licenses 2 Gene Therapies, Agile To Undertake Additional Study Of Contraceptive Patch

Benzinga.com  December 14, 2018

Second Sight to Present at the 11th Annual LD Micro Main Event Conference in Los Angeles on Wednesday, December 5th

GlobeNewswire November 27, 2018

Second Sight Reports Third Quarter 2018 Financial Results

GlobeNewswire November 7, 2018

Second Sight Announces Final 2019 Medicare Hospital Outpatient Payment Rate for the Argus II Retinal Prosthesis System

GlobeNewswire November 6, 2018

Second Sight to Discuss Third Quarter 2018 Financial Results on November 7, 2018 Conference Call

Business Wire October 30, 2018